garcinol has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chatterjee Debnath, M; Chattopadhyay, D; Dewanjee, S; Ganguly, S; Gaonkar, RH; Gupta, A; Sinha, S | 1 |
| Debnath, MC; Ganguly, S; Gaonkar, RH; Mukherjee, B; Mukhopadhyay, R; Paul, B | 1 |
2 other study(ies) available for garcinol and B16 Melanoma
| Article | Year |
|---|---|
Garcinol loaded vitamin E TPGS emulsified PLGA nanoparticles: preparation, physicochemical characterization, in vitro and in vivo studies.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Chemical Phenomena; Drug Carriers; Drug Liberation; Emulsions; Lactic Acid; Melanoma, Experimental; Mice; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Spectroscopy, Fourier Transform Infrared; Terpenes; Tissue Distribution; Vitamin E; X-Ray Diffraction | 2017 |
Garcinol-loaded novel cationic nanoliposomes:
Topics: Animals; Antineoplastic Agents; Cations; Cell Line, Tumor; Liposomes; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Nanocapsules; Terpenes | 2019 |